uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Comments
Loading...

U.S. stocks were lower, with the Dow Jones index falling around 550 points on Thursday.

Shares of uniQure N.V. QURE rose sharply during Thursday's session after the company was granted FDA granted Breakthrough Therapy designation for AMT-130 for the treatment of Huntington’s disease.

uniQure shares jumped 45.3% to $13.65 on Thursday.

Here are some other big stocks recording gains in today's session.

  • Structure Therapeutics Inc. GPCR gained 21.4% to $22.49.
  • Hertz Global Holdings, Inc. HTZ rose 20.3% to $6.99 after Pershing Square Capital Management disclosed a stake via a 13F. CNBC reported that Pershing Square’s stake is 19.8%, through shares & swaps.
  • Eli Lilly and Company LLY gained 15.3% to $847.08 after the company announced topline Phase 3 results from its ACHIEVE-1 trial, which showed orforglipron demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.
  • Capricor Therapeutics, Inc. CAPR rose 13.8% to $10.97.
  • ClearPoint Neuro, Inc. CLPT gained 13% to $13.02.
  • VersaBank VBNK rose 12% to $10.91.
  • Evotec SE EVO jumped 10.7% to $3.6200 following FY24 financial results.
  • Avis Budget Group, Inc. CAR gained 10.1% to $80.00. The move came as investors responded to news that billionaire investor Bill Ackman’s Pershing Square Capital Management significantly increased its stake in Hertz Global Holdings Inc HTZ.
  • Insteel Industries, Inc. IIIN gained 9.1% to $29.15 following second-quarter results.
  • Fidelity National Information Services, Inc. FIS shares jumped 7% to $73.41. Fidelity National Information Services unveiled two strategic moves—acquiring Global Payments' Issuer Solutions unit and selling its remaining stake in Worldpay.
  • Dollar Tree, Inc. DLTR gained 4.4% to $76.40.

Now Read This:

Photo via Shutterstock

Got Questions? Ask
Which biotech stocks could follow uniQure's rise?
How can Hertz Global leverage its new investor?
What impact will Eli Lilly's trial results have on competitors?
Are there emerging biotech firms to watch after uniQure?
Which investment strategies benefit from Hertz Global's stake increase?
Could Capricor Therapeutics gain traction from market momentum?
How might Fidelity National Information Services's moves affect fintech?
Will Evotec SE's results attract more investors?
Which healthcare ETFs could gain from Eli Lilly advancements?
What other companies may experience shifts after uniQure's FDA news?
Market News and Data brought to you by Benzinga APIs

Posted In: